(19)
(11) EP 1 115 867 A1

(12)

(43) Date of publication:
18.07.2001 Bulletin 2001/29

(21) Application number: 99949626.8

(22) Date of filing: 20.09.1999
(51) International Patent Classification (IPC)7C12N 15/24, C07K 14/54, C12Q 1/68, C07K 16/24, C12N 5/10, G01N 33/68, C12N 5/08
(86) International application number:
PCT/US9920/871
(87) International publication number:
WO 0017/362 (30.03.2000 Gazette 2000/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.09.1998 US 157749
27.04.1999 US 131298 P

(71) Applicant: SCHERING CORPORATION
Kenilworth,New Jersey 07033-0530 (US)

(72) Inventor:
  • BAZAN, J., Fernando
    Menlo Park, CA 94025 (US)

(74) Representative: Ritter, Stephen David et al
Mathys & Squire100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

   


(54) HUMAN INTERLEUKIN-B50. THERAPEUTIC USES